Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Textual)

v3.8.0.1
Commitments and Contingencies (Details Textual) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 01, 2017
Jul. 15, 2011
Mar. 31, 2017
Mar. 31, 2016
Jun. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Commitments And Contingencies [Line Items]                
Royalty Expense           $ 820,000 $ 1,093,000  
Accrued Liabilities, Current           4,270,000 5,224,000  
Accounts Payable, Current           1,641,000 2,614,000  
Business Combination, Contingent Consideration, Liability               $ 2,600,000
Revenues           19,565,000 16,294,000  
Installment Two [Member]                
Commitments And Contingencies [Line Items]                
Business Combination Agreed Contingent Consideration Payable Ratio In Excess Of Certain Revenue Targets     3.5          
Installment Two [Member] | Two Thousand Fifteen MIST Therapy [Member]                
Commitments And Contingencies [Line Items]                
Revenues     $ 10,200,000          
Installment Two [Member] | Two Thousands Sixteen Mist Therapy [Member]                
Commitments And Contingencies [Line Items]                
Revenues     10,500,000          
Installment One [Member] | Two Thousand Fifteen MIST Therapy [Member]                
Commitments And Contingencies [Line Items]                
Revenues       $ 10,200,000        
Installment One [Member] | Two Thousand Fourteen MIST Therapy [Member]                
Commitments And Contingencies [Line Items]                
Revenues       $ 8,700,000        
AIQA Cedar Inc [Member]                
Commitments And Contingencies [Line Items]                
Accounts Payable, Current           0 598,000  
Alliqua Biomedical Subsidiary [Member]                
Commitments And Contingencies [Line Items]                
Contractual Obligation, Due in Next Twelve Months             600,000  
Royalty Expense           1,900    
Human Longevity, Inc [Member]                
Commitments And Contingencies [Line Items]                
Revenue Recognition, Milestone Method, Milestone Expenses             1,000,000  
Contingent Consideration [Member] | Installment Two [Member]                
Commitments And Contingencies [Line Items]                
Payments to Acquire Businesses, Gross     $ 675,000          
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares     101,000          
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned     $ 675,000          
Contingent Consideration [Member] | Installment One [Member]                
Commitments And Contingencies [Line Items]                
Business Combination Agreed Contingent Consideration Payable Ratio In Excess Of Certain Revenue Targets       3.5        
Payments to Acquire Businesses, Gross       $ 2,600,000        
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares       98,600        
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned       $ 2,600,000        
Choice Therapeutics, Inc. [Member]                
Commitments And Contingencies [Line Items]                
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares         132,000      
Business Combination, Contingent Consideration, Liability         $ 500,000      
Cellularity Inc [Member]                
Commitments And Contingencies [Line Items]                
Royalty Expense           818,000 493,000  
Accrued Liabilities, Current           $ 227,000 197,000  
Long-term Purchase Commitment, Amount $ 842,000              
Cellularity Inc [Member] | First Commercial Sale [Member]                
Commitments And Contingencies [Line Items]                
Contractual Obligation, Due in Next Twelve Months             500,000  
Cellularity Inc [Member] | Second Commercial Sale [Member]                
Commitments And Contingencies [Line Items]                
Contractual Obligation, Due in Next Twelve Months             $ 500,000  
Noble Fiber Technologies License Agreement [Member]                
Commitments And Contingencies [Line Items]                
Royalty Fee Percentage   9.75%